Ümmühan Tuğba Tümüklü
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ümmühan Tuğba Tümüklü has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Zehra Seyfikli
BOZOK ÜNİVERSİTESİ, TIP FAKÜLTESİ
4 shared publications - Duygu Felek
Department of Internal Medicine, Faculty of Medicine, Yozgat Bozok University, 66100 Yozgat, Türkiye
3 shared publications - Can Kerestecioğlu
BOZOK ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - İsMail Ağı
YOZGAT ŞEHİR HASTANESİ
1 shared publication - Mert Üstündağ
SİVAS CUMHURİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ
1 shared publication - Mustafa Fatih Erkoç
Department of Radiology, Faculty of Medicine, Yozgat Bozok University, 66100 Yozgat, Turkey
1 shared publication
Latest Publications
- 15 March 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (1) , 37-47
Clinical Evaluation of Systemic Inflammation Markers in Patients Diagnosed with Pulmonary Tuberculosis
Objective: This study aimed to investigate the levels of systemic inflammation markers—including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), hematological ratios, and complete blood count parameters—in individuals diagnosed with pulmonary tuberculosis (TBC). The clinical significance of these biomarkers in the diagnosis, disease activity, and treatment response was evaluated, and their associations with age, sex, and comorbidities were also analyzed.Materials and Methods: Following ethics approval (2025-GOKAEK-2517), hospital records of patients aged 18–80 years diagnosed with pulmonary tuberculosis between 2023 and 2025 at Yozgat Bozok University and Sivas Cumhuriyet University were retrospectively reviewed. The control group consisted of healthy individuals who presented during the same period. Hemogram parameters, CRP, ESR, and the Systemic Immune-Inflammation Index (SII) were assessed, and statistical analyses were performed using SPSS v22.0.Results: A total of 134 individuals (67 TBC and 67 controls) were included. In the TBC group, 70.1% were male, and the mean age was 48.76 ± 18.01 years. Comorbidities were present in 70.1% of patients, most commonly COPD, hypertension, and coronary artery disease. The TBC group demonstrated significantly higher leukocyte, neutrophil, monocyte, platelet, CRP, ESR, and SII levels, while hemoglobin and lymphocyte levels were significantly lower (all p < 0.0001). Although the mean SII value was elevated (2772.51 ± 4004.20), it did not show a significant association with diagnostic test results or clinical outcomes.Conclusion: The markedly elevated SII levels in patients with pulmonary tuberculosis suggest that this index may serve as a potential biomarker reflecting increased systemic inflammation. However, its limited correlation with diagnostic and clinical endpoints indicates that it should be considered a supportive—not standalone—parameter in clinical evaluation.
- 15 March 2026
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 16 (1) , 37-47
Clinical Evaluation of Systemic Inflammation Markers in Patients Diagnosed with Pulmonary Tuberculosis
Objective: This study aimed to investigate the levels of systemic inflammation markers—including C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), hematological ratios, and complete blood count parameters—in individuals diagnosed with pulmonary tuberculosis (TBC). The clinical significance of these biomarkers in the diagnosis, disease activity, and treatment response was evaluated, and their associations with age, sex, and comorbidities were also analyzed.Materials and Methods: Following ethics approval (2025-GOKAEK-2517), hospital records of patients aged 18–80 years diagnosed with pulmonary tuberculosis between 2023 and 2025 at Yozgat Bozok University and Sivas Cumhuriyet University were retrospectively reviewed. The control group consisted of healthy individuals who presented during the same period. Hemogram parameters, CRP, ESR, and the Systemic Immune-Inflammation Index (SII) were assessed, and statistical analyses were performed using SPSS v22.0.Results: A total of 134 individuals (67 TBC and 67 controls) were included. In the TBC group, 70.1% were male, and the mean age was 48.76 ± 18.01 years. Comorbidities were present in 70.1% of patients, most commonly COPD, hypertension, and coronary artery disease. The TBC group demonstrated significantly higher leukocyte, neutrophil, monocyte, platelet, CRP, ESR, and SII levels, while hemoglobin and lymphocyte levels were significantly lower (all p < 0.0001). Although the mean SII value was elevated (2772.51 ± 4004.20), it did not show a significant association with diagnostic test results or clinical outcomes.Conclusion: The markedly elevated SII levels in patients with pulmonary tuberculosis suggest that this index may serve as a potential biomarker reflecting increased systemic inflammation. However, its limited correlation with diagnostic and clinical endpoints indicates that it should be considered a supportive—not standalone—parameter in clinical evaluation.
- 31 January 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (1) , 91-101
The Relationship Between Systemic Inflammatory Response Index and Systemic Immune-Inflammation Index and Diagnostic Rates of Myocardial Infarction, Pulmonary Thromboembolism, and Aortic Dissection in Patients Presenting to the Emergency Department with Chest Pain
Background: This study aims to investigate the association between the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune-Inflammation Index (SII) and serious cardiovascular diagnoses such as myocardial infarction, pulmonary thromboembolism, and aortic dissection in patients presenting to the emergency department with chest pain. Additionally, it evaluates the potential role of these biomarkers in supporting clinical decision-making processes. Methods: This retrospective cross-sectional study included 612 patients aged 18–100 years who presented with chest pain to the Emergency Department of Yozgat City Hospital between July 1, 2025, and July 31, 2025. Demographic characteristics, final diagnoses, and laboratory parameters were analyzed, and SII and SIRI values were calculated accordingly. Statistical analyses were conducted using SPSS 22 with appropriate statistical tests. Results: In the STEMI group, the mean SII was 1725.90 ± 1274.25 and the mean SIRI was 4.50 ± 3.66. In the NSTEMI group, these values were 1410.94 ± 1341.51 and 3.28 ± 2.79, respectively. Patients with non-cardiovascular causes exhibited significantly lower SII and SIRI levels. Based on ROC analysis, the AUC for SII was 0.738 with a cut-off value of 658, while the AUC for SIRI was 0.723 with a cut-off of 1.92. A positive and significant correlation was found between SII/SIRI and troponin and D-dimer levels (p < 0.001). Conclusion: SII and SIRI levels are markedly elevated in chest pain of cardiovascular origin and may serve as useful adjunct biomarkers in the diagnostic differentiation of these conditions.
- 31 January 2026
- Published by Archives of Current Medical Research in Archives of Current Medical Research
- Vol. 7 (1) , 91-101
The Relationship Between Systemic Inflammatory Response Index and Systemic Immune-Inflammation Index and Diagnostic Rates of Myocardial Infarction, Pulmonary Thromboembolism, and Aortic Dissection in Patients Presenting to the Emergency Department with Chest Pain
Background: This study aims to investigate the association between the Systemic Inflammatory Response Index (SIRI) and the Systemic Immune-Inflammation Index (SII) and serious cardiovascular diagnoses such as myocardial infarction, pulmonary thromboembolism, and aortic dissection in patients presenting to the emergency department with chest pain. Additionally, it evaluates the potential role of these biomarkers in supporting clinical decision-making processes. Methods: This retrospective cross-sectional study included 612 patients aged 18–100 years who presented with chest pain to the Emergency Department of Yozgat City Hospital between July 1, 2025, and July 31, 2025. Demographic characteristics, final diagnoses, and laboratory parameters were analyzed, and SII and SIRI values were calculated accordingly. Statistical analyses were conducted using SPSS 22 with appropriate statistical tests. Results: In the STEMI group, the mean SII was 1725.90 ± 1274.25 and the mean SIRI was 4.50 ± 3.66. In the NSTEMI group, these values were 1410.94 ± 1341.51 and 3.28 ± 2.79, respectively. Patients with non-cardiovascular causes exhibited significantly lower SII and SIRI levels. Based on ROC analysis, the AUC for SII was 0.738 with a cut-off value of 658, while the AUC for SIRI was 0.723 with a cut-off of 1.92. A positive and significant correlation was found between SII/SIRI and troponin and D-dimer levels (p < 0.001). Conclusion: SII and SIRI levels are markedly elevated in chest pain of cardiovascular origin and may serve as useful adjunct biomarkers in the diagnostic differentiation of these conditions.
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 507-517
Yozgat Bozok Üniversitesi Araştirma Ve Uygulama Hastanesi Cerrahi Kliniklerinde Yatışı Yapılan Hastalarda OUAS (Obstrüktif Uyku Apne Sendromu) Prevelansı ve Farkındalığının Değerlendirilmesi
Amaç: Bu çalışmanın amacı, Yozgat Bozok Üniversitesi Araştırma ve Uygulama Hastanesi cerrahi kliniklerinde hospitalize edilen hastalarda Obstrüktif Uyku Apne Sendromu (OUAS) prevalansını belirlemek ve bu bireylerin hastalık farkındalık düzeylerini değerlendirmektir. Elde edilecek veriler ile preoperatif dönemde uygulanacak sistematik tarama protokollerinin hasta güvenliği ve cerrahi sonuçlar üzerindeki etkisinin ortaya konması hedeflenmektedir. Gereç ve Yöntem: Bu çalışma, Yozgat Bozok Üniversitesi Hastanesi’nin cerrahi kliniklerinde 2024 yılı içerisinde yatırılarak tedavi edilen erişkin bireylerde yürütülen kesitsel, tanımlayıcı ve analitik bir araştırmadır. Çalışmaya 18 yaş üzeri, bilgilendirilmiş onam vermiş ve iletişim kurabilen hastalar dahil edilmiş; OUAS tanısı ile tedavi görmekte olanlar, bilişsel bozukluk veya akut psikiyatrik hastalığı olanlar çalışma dışında bırakılmıştır. Veriler, yüz yüze görüşmelerle yapılandırılmış anket formları ve Epworth Uykululuk Ölçeği kullanılarak toplanmış, pozitif tarama sonuçları polisomnografik değerlendirme için riskli kabul edilmiştir. Etik kurul onayı alınarak Helsinki Deklarasyonu ilkelerine uygun şekilde yürütülen araştırmanın verileri SPSS 20.0 programında analiz edilmiş, uygun parametrik ve non-parametrik testler kullanılmış ve istatistiksel anlamlılık düzeyi p
- 15 December 2025
- Published by Bozok Tip Dergisi in Bozok Tıp Dergisi
- Vol. 15 (4) , 507-517
Yozgat Bozok Üniversitesi Araştirma Ve Uygulama Hastanesi Cerrahi Kliniklerinde Yatışı Yapılan Hastalarda OUAS (Obstrüktif Uyku Apne Sendromu) Prevelansı ve Farkındalığının Değerlendirilmesi
Amaç: Bu çalışmanın amacı, Yozgat Bozok Üniversitesi Araştırma ve Uygulama Hastanesi cerrahi kliniklerinde hospitalize edilen hastalarda Obstrüktif Uyku Apne Sendromu (OUAS) prevalansını belirlemek ve bu bireylerin hastalık farkındalık düzeylerini değerlendirmektir. Elde edilecek veriler ile preoperatif dönemde uygulanacak sistematik tarama protokollerinin hasta güvenliği ve cerrahi sonuçlar üzerindeki etkisinin ortaya konması hedeflenmektedir. Gereç ve Yöntem: Bu çalışma, Yozgat Bozok Üniversitesi Hastanesi’nin cerrahi kliniklerinde 2024 yılı içerisinde yatırılarak tedavi edilen erişkin bireylerde yürütülen kesitsel, tanımlayıcı ve analitik bir araştırmadır. Çalışmaya 18 yaş üzeri, bilgilendirilmiş onam vermiş ve iletişim kurabilen hastalar dahil edilmiş; OUAS tanısı ile tedavi görmekte olanlar, bilişsel bozukluk veya akut psikiyatrik hastalığı olanlar çalışma dışında bırakılmıştır. Veriler, yüz yüze görüşmelerle yapılandırılmış anket formları ve Epworth Uykululuk Ölçeği kullanılarak toplanmış, pozitif tarama sonuçları polisomnografik değerlendirme için riskli kabul edilmiştir. Etik kurul onayı alınarak Helsinki Deklarasyonu ilkelerine uygun şekilde yürütülen araştırmanın verileri SPSS 20.0 programında analiz edilmiş, uygun parametrik ve non-parametrik testler kullanılmış ve istatistiksel anlamlılık düzeyi p
- Open Access
- 15 October 2025
- Published by MediHealth Academy in Journal of Radiology in Medicine
- Vol. 2 (4) , 76-80
Radiological evaluation of the impact of chronic obstructive pulmonary disease on ascending aortic diameter in hypertensive patients
Aims: This study aims to radiologically evaluate the impact of chronic obstructive pulmonary disease (COPD) on the diameter of the ascending aorta (AsAo) in individuals diagnosed with hypertension and to explore the potential structural effects of COPD on the cardiovascular system. Methods: This retrospective cross-sectional study was conducted at Yozgat Bozok University Research and Training Hospital. Clinical and radiological data of 60 hypertensive individuals who underwent thoracic computed tomography (CT) between January 1, 2023, and June 1, 2025, were analyzed. Participants were divided into two groups based on the presence or absence of a COPD diagnosis. Ascending aorta and aortic arch (Arcus Ao) diameters were measured from CT images. Clinical variables, comorbidities, and lipid profiles were statistically evaluated. Results: The mean age of participants was significantly higher in the COPD group (73.8 ± 7.92 years) compared to the control group (67.93 ± 12.59 years) (p = 0.036). The mean AsAo diameter was 40.40 ± 4.90 mm in the COPD group and 36.01 ± 3.79 mm in the control group, revealing a statistically significant difference (p = 0.00028). No significant difference was found between the groups regarding Arcus Ao diameter (p = 0.103). Among lipid parameters, there were no significant differences in HDL, LDL, or total cholesterol levels; however, triglyceride levels approached statistical significance (p = 0.069). Conclusion: The findings suggest that COPD is not merely a respiratory condition but also a systemic disease with notable vascular implications. The significant increase in AsAo diameter in the COPD group may be attributed to chronic inflammation, endothelial dysfunction, and degeneration of elastic fibers associated with the disease. The absence of a significant difference in Arcus Ao diameter may be related to the anatomically stable structure of this segment. The higher comorbidity burden and older age observed in COPD patients further support the systemic nature of the disease.
- 15 October 2025
- Published by MediHealth Academy in Journal of Radiology in Medicine
- Vol. 2 (4) , 76-80
Open AccessRadiological evaluation of the impact of chronic obstructive pulmonary disease on ascending aortic diameter in hypertensive patients
Aims: This study aims to radiologically evaluate the impact of chronic obstructive pulmonary disease (COPD) on the diameter of the ascending aorta (AsAo) in individuals diagnosed with hypertension and to explore the potential structural effects of COPD on the cardiovascular system. Methods: This retrospective cross-sectional study was conducted at Yozgat Bozok University Research and Training Hospital. Clinical and radiological data of 60 hypertensive individuals who underwent thoracic computed tomography (CT) between January 1, 2023, and June 1, 2025, were analyzed. Participants were divided into two groups based on the presence or absence of a COPD diagnosis. Ascending aorta and aortic arch (Arcus Ao) diameters were measured from CT images. Clinical variables, comorbidities, and lipid profiles were statistically evaluated. Results: The mean age of participants was significantly higher in the COPD group (73.8 ± 7.92 years) compared to the control group (67.93 ± 12.59 years) (p = 0.036). The mean AsAo diameter was 40.40 ± 4.90 mm in the COPD group and 36.01 ± 3.79 mm in the control group, revealing a statistically significant difference (p = 0.00028). No significant difference was found between the groups regarding Arcus Ao diameter (p = 0.103). Among lipid parameters, there were no significant differences in HDL, LDL, or total cholesterol levels; however, triglyceride levels approached statistical significance (p = 0.069). Conclusion: The findings suggest that COPD is not merely a respiratory condition but also a systemic disease with notable vascular implications. The significant increase in AsAo diameter in the COPD group may be attributed to chronic inflammation, endothelial dysfunction, and degeneration of elastic fibers associated with the disease. The absence of a significant difference in Arcus Ao diameter may be related to the anatomically stable structure of this segment. The higher comorbidity burden and older age observed in COPD patients further support the systemic nature of the disease.
- Open Access
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 64-72
Obstructive sleep apnea and comorbidities: a current perspective from diagnosis to treatment
Obstructive Sleep Apnea Syndrome (OSAS) is a significant health condition characterized by recurrent upper airway obstructions during sleep, with widespread systemic consequences. This review aims to present a comprehensive overview of OSAS, encompassing its pathophysiological foundations, risk factors, clinical manifestations, associated comorbidities, and contemporary diagnostic and therapeutic strategies. OSAS not only impairs sleep quality but also adversely affects cardiovascular, metabolic, neurocognitive, and psychological health, thereby reducing both lifespan and quality of life. While polysomnography remains the gold standard for diagnosis, home sleep tests and subjective assessment tools are increasingly utilized in clinical practice. Treatment approaches vary depending on disease severity and individual characteristics, ranging from lifestyle modifications and positive airway pressure devices to oral appliances and surgical interventions. In recent years, promising innovations such as neurostimulation and pharmacotherapy have emerged in OSAS management. This review highlights the multidimensional impact of OSAS at both individual and societal levels, emphasizing the need for early diagnosis and integrated treatment strategies.
- 29 August 2025
- Published by MediHealth Academy in Intercontinental Journal of Internal Medicine
- Vol. 3 (3) , 64-72
Open AccessObstructive sleep apnea and comorbidities: a current perspective from diagnosis to treatment
Obstructive Sleep Apnea Syndrome (OSAS) is a significant health condition characterized by recurrent upper airway obstructions during sleep, with widespread systemic consequences. This review aims to present a comprehensive overview of OSAS, encompassing its pathophysiological foundations, risk factors, clinical manifestations, associated comorbidities, and contemporary diagnostic and therapeutic strategies. OSAS not only impairs sleep quality but also adversely affects cardiovascular, metabolic, neurocognitive, and psychological health, thereby reducing both lifespan and quality of life. While polysomnography remains the gold standard for diagnosis, home sleep tests and subjective assessment tools are increasingly utilized in clinical practice. Treatment approaches vary depending on disease severity and individual characteristics, ranging from lifestyle modifications and positive airway pressure devices to oral appliances and surgical interventions. In recent years, promising innovations such as neurostimulation and pharmacotherapy have emerged in OSAS management. This review highlights the multidimensional impact of OSAS at both individual and societal levels, emphasizing the need for early diagnosis and integrated treatment strategies.
- Open Access
- 20 August 2025
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 3 (3) , 70-75
Investigation of systemic inflammation levels in patients followed up with a diagnosis of pneumonia
Aims: Although pneumonia is typically considered a localized infection, it can trigger a systemic inflammatory response. Systemic inflammation is characterized by cytokine release throughout the body, increased acute phase reactants, and immune cell imbalance, which can elevate disease severity and the risk of complications. Recently, hematological parameters such as the systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) have gained prominence in assessing this inflammatory response. This study aimed to evaluate systemic inflammation levels in patients diagnosed with pneumonia using SII and SIRI, and to analyze their correlation with classical inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Methods: A total of 50 patients hospitalized and followed up with a diagnosis of pneumonia between 01.01.2023 and 01.06.2025 at Yozgat Bozok University Research and Training Hospital's Departments of Pulmonology and Internal Medicine, and 50 healthy individuals admitted to the same clinics during the same period were included in the study. Demographic data (age, gender), smoking status, clinical histories, laboratory values, treatment processes, complete blood count (CBC), CRP level, and ESR were recorded. Patients with active malignancy, hematological or autoimmune diseases, or those under immunosuppressive therapy were excluded. SII and SIRI values were calculated for each participant. Results: Of the participants, 66% were male and 34% female, with a mean age of 61.98 ± 16.78 years in the pneumonia group and 59.20 ± 16.10 years in the control group. SII was significantly higher in the pneumonia group (1301.28 ± 886.78) compared to the control group (545.20 ± 488.26), as was SIRI (5.66 ± 6.58 vs. 0.91 ± 1.21) (p<0.001 for both). Smokers exhibited significantly higher SII (1535.9 ± 1094.1 vs. 977.2 ± 560.3) and SIRI (7.51 ± 8.13 vs. 3.10 ± 3.72) values than non-smokers (p=0.031 and p=0.014, respectively). Conclusion: This study demonstrated that new-generation inflammation indices such as SII and SIRI reflect the intensity of inflammatory response in pneumonia patients and show significant correlation with CRP levels. These findings suggest that integrating these indices into clinical practice may serve as effective tools in evaluating disease prognosis and monitoring treatment response.
- 20 August 2025
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 3 (3) , 70-75
Open AccessInvestigation of systemic inflammation levels in patients followed up with a diagnosis of pneumonia
Aims: Although pneumonia is typically considered a localized infection, it can trigger a systemic inflammatory response. Systemic inflammation is characterized by cytokine release throughout the body, increased acute phase reactants, and immune cell imbalance, which can elevate disease severity and the risk of complications. Recently, hematological parameters such as the systemic immune-inflammation index (SII) and systemic inflammatory response index (SIRI) have gained prominence in assessing this inflammatory response. This study aimed to evaluate systemic inflammation levels in patients diagnosed with pneumonia using SII and SIRI, and to analyze their correlation with classical inflammatory biomarkers such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). Methods: A total of 50 patients hospitalized and followed up with a diagnosis of pneumonia between 01.01.2023 and 01.06.2025 at Yozgat Bozok University Research and Training Hospital's Departments of Pulmonology and Internal Medicine, and 50 healthy individuals admitted to the same clinics during the same period were included in the study. Demographic data (age, gender), smoking status, clinical histories, laboratory values, treatment processes, complete blood count (CBC), CRP level, and ESR were recorded. Patients with active malignancy, hematological or autoimmune diseases, or those under immunosuppressive therapy were excluded. SII and SIRI values were calculated for each participant. Results: Of the participants, 66% were male and 34% female, with a mean age of 61.98 ± 16.78 years in the pneumonia group and 59.20 ± 16.10 years in the control group. SII was significantly higher in the pneumonia group (1301.28 ± 886.78) compared to the control group (545.20 ± 488.26), as was SIRI (5.66 ± 6.58 vs. 0.91 ± 1.21) (p<0.001 for both). Smokers exhibited significantly higher SII (1535.9 ± 1094.1 vs. 977.2 ± 560.3) and SIRI (7.51 ± 8.13 vs. 3.10 ± 3.72) values than non-smokers (p=0.031 and p=0.014, respectively). Conclusion: This study demonstrated that new-generation inflammation indices such as SII and SIRI reflect the intensity of inflammatory response in pneumonia patients and show significant correlation with CRP levels. These findings suggest that integrating these indices into clinical practice may serve as effective tools in evaluating disease prognosis and monitoring treatment response.
- Open Access
- 29 May 2025
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 3 (2) , 24-31
The impact of coexisting metabolic syndrome on asthma control in patients diagnosed with asthma
Aims: Asthma is a disease characterized by diffuse and reversible narrowing of the airways, affecting approximately 300 million people worldwide. Metabolic syndrome, on the other hand, is a fatal endocrinopathy that begins with insulin resistance. Numerous studies have investigated the impact of metabolic syndrome on airway inflammation in patients with asthma. In this study, we aimed to investigate the coexistence of metabolic syndrome in patients followed up with a diagnosis of asthma and its impact on asthma control using the asthma control test (ACT). Methods: A total of 50 patients, including 10 men and 40 women aged between 18 and 70 years, who presented to the asthma outpatient clinic of Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital and were diagnosed with asthma, were included in the study. Participants completed a questionnaire assessing demographic characteristics and medical history. Subsequently, height, weight, waist circumference, and triceps skinfold thickness measurements were taken. Arterial blood pressure was measured, and blood samples were collected after 12 hours of fasting to evaluate serum triglyceride (TG), HDL, and fasting glucose levels, along with a complete blood count. Pulmonary function tests were performed, and participants responded to the short form of the International Physical Activity Questionnaire (IPAQ). Results: Upon evaluation, 30% of the cases were diagnosed with metabolic syndrome. Metabolic syndrome was diagnosed in 40% of male and 27.5% of female patients. Among the 50 participants, 16 (32%) were diagnosed with obesity, 19 (38%) with hypertension, and 1 (2%) with diabetes mellitus. The average duration of asthma follow-up was calculated as 10.8±8.7 years. The prevalence of metabolic syndrome was found to be higher in postmenopausal women compared to premenopausal women, whereas among women using oral contraceptives, the diagnosis of metabolic syndrome was lower than in non-users; however, this was not statistically significant (p>0.05). However, waist circumference measurements were significantly higher in those with metabolic syndrome compared to those without (p<0.05). A significant association was found between serum TG levels and metabolic syndrome diagnosis, while no significant relationship was observed for fasting blood glucose and serum HDL levels. Both systolic and diastolic blood pressure values were found to be higher in individuals with metabolic syndrome, with a statistically significant association between blood pressure values and the diagnosis of metabolic syndrome. According to the ACT results, 4 patente (8%) were under control, 17 (34%) were partially controlled, and 29 (58%) were uncontrolled. Among patients with metabolic syndrome, the forced expiratory volume in 1 second (FEV1) was found to be lower with borderline values. No significant association was found between physical activity levels and metabolic syndrome. Both groups, with and without metabolic syndrome, had low ACT scores, and no significant relationship was found between metabolic syndrome and ACT scores. Conclusion: Nonetheless, based on the findings of this study, we believe that metabolic syndrome should also be considered when planning treatment for asthmatic patients.
- 29 May 2025
- Published by MediHealth Academy in Journal of Pulmonology and Intensive Care
- Vol. 3 (2) , 24-31
Open AccessThe impact of coexisting metabolic syndrome on asthma control in patients diagnosed with asthma
Aims: Asthma is a disease characterized by diffuse and reversible narrowing of the airways, affecting approximately 300 million people worldwide. Metabolic syndrome, on the other hand, is a fatal endocrinopathy that begins with insulin resistance. Numerous studies have investigated the impact of metabolic syndrome on airway inflammation in patients with asthma. In this study, we aimed to investigate the coexistence of metabolic syndrome in patients followed up with a diagnosis of asthma and its impact on asthma control using the asthma control test (ACT). Methods: A total of 50 patients, including 10 men and 40 women aged between 18 and 70 years, who presented to the asthma outpatient clinic of Atatürk Chest Diseases and Thoracic Surgery Training and Research Hospital and were diagnosed with asthma, were included in the study. Participants completed a questionnaire assessing demographic characteristics and medical history. Subsequently, height, weight, waist circumference, and triceps skinfold thickness measurements were taken. Arterial blood pressure was measured, and blood samples were collected after 12 hours of fasting to evaluate serum triglyceride (TG), HDL, and fasting glucose levels, along with a complete blood count. Pulmonary function tests were performed, and participants responded to the short form of the International Physical Activity Questionnaire (IPAQ). Results: Upon evaluation, 30% of the cases were diagnosed with metabolic syndrome. Metabolic syndrome was diagnosed in 40% of male and 27.5% of female patients. Among the 50 participants, 16 (32%) were diagnosed with obesity, 19 (38%) with hypertension, and 1 (2%) with diabetes mellitus. The average duration of asthma follow-up was calculated as 10.8±8.7 years. The prevalence of metabolic syndrome was found to be higher in postmenopausal women compared to premenopausal women, whereas among women using oral contraceptives, the diagnosis of metabolic syndrome was lower than in non-users; however, this was not statistically significant (p>0.05). However, waist circumference measurements were significantly higher in those with metabolic syndrome compared to those without (p<0.05). A significant association was found between serum TG levels and metabolic syndrome diagnosis, while no significant relationship was observed for fasting blood glucose and serum HDL levels. Both systolic and diastolic blood pressure values were found to be higher in individuals with metabolic syndrome, with a statistically significant association between blood pressure values and the diagnosis of metabolic syndrome. According to the ACT results, 4 patente (8%) were under control, 17 (34%) were partially controlled, and 29 (58%) were uncontrolled. Among patients with metabolic syndrome, the forced expiratory volume in 1 second (FEV1) was found to be lower with borderline values. No significant association was found between physical activity levels and metabolic syndrome. Both groups, with and without metabolic syndrome, had low ACT scores, and no significant relationship was found between metabolic syndrome and ACT scores. Conclusion: Nonetheless, based on the findings of this study, we believe that metabolic syndrome should also be considered when planning treatment for asthmatic patients.